AI
By
Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?
Key Highlights: Autonomous Camera Enables Solo Laparoscopic Surgery At Clínica Las Condes in Santiago, Chile, a gallbladder removal…
Will Tempus AI’s FDA Clearance Redefine the Future of Cardiac Imaging?
Key Highlights: Tempus AI Secures FDA Clearance for Tempus Pixel Tempus AI announced that its advanced imaging platform,…
Can DeepMind’s Demis Hassabis Slash Drug Discovery Timelines From Years to Months—And What Does That Mean for Pharma Startups?
Key Highlights: What Hassabis Says: A Turning Point for Drug DiscoveryDemis Hassabis, CEO of DeepMind, recently told Bloomberg…
Is Lilly’s “TuneLab” the Breakthrough AI Collaboration Model Biotech Startups Have Been Waiting For?
Key Highlights A bold move: Lilly democratizes AI for biotechEli Lilly has launched TuneLab, a novel AI platform…
Can Phare Bio and Basilea’s AI-Driven Alliance Redefine Antibiotic Discovery and Change the Fight Against Drug-Resistant Infections Worldwide?
Executive Takeaways: • First-of-its-kind partnership aligns AI-driven antibiotic design directly with patient-centric target product profiles, setting a new…
FDA Qualifies First AI Drug Development Tool, Will Be Used in ‘MASH’ Clinical Trials to Accelerate Liver Disease Drug Development
The U.S. Food and Drug Administration (FDA) has qualified AIM-NASH, the first AI-based tool designed to assist doctors…
